Analysis Of Income And Expense [Abstract]

BioPorto - Filing #1343302

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
30,958,000 DKK
28,969,000 DKK
Material income and expense [abstract]
Research and development expense
25,446,000 DKK
34,938,000 DKK
Sales and marketing expense
18,871,000 DKK
21,219,000 DKK
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
459,000 DKK
115,000 DKK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
55,869,000 DKK
76,038,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.